The impact of the COVID-19 pandemic on ICU clinical trials: a description of one research team’s experience

BACKGROUND: Disruptions to clinical trials conducted in the intensive care unit (ICU) due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2; coronavirus disease 2019 [COVID-19]) pandemic included fewer new trials activated and more trials stopped. While a number of ongoing, non-COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Chlan, Linda L., Tracy, Mary Fran, Ask, Jessica, Lal, Amos, Mandrekar, Jay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172070/
https://www.ncbi.nlm.nih.gov/pubmed/37165383
http://dx.doi.org/10.1186/s13063-023-07355-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172070/
https://www.ncbi.nlm.nih.gov/pubmed/37165383
http://dx.doi.org/10.1186/s13063-023-07355-4

Ejemplares similares